May 2, 2025
At Envol Biomedical, we take pride in our reputation for delivering exceptional preclinical research services across a variety of therapeutic areas, including neuro, ocular, cardiovascular, and interventional models. Our commitment to innovation, coupled with our team of dedicated scientists, allows us to provide our clients with cutting-edge solutions that drive successful outcomes. We also recognize the importance of collaborating with specialized experts who can help us continue to elevate our offerings, and ensure we stay ahead of the curve in this ever-evolving industry.
Our recent partnership with Endpoint Preclinical has been a demonstrable example of this sort of collaboration. It has been instrumental in expanding our capabilities and enhancing the services we provide our customers. With experts like Eric Adams, a leader in neuro models, and Ryan Boyd, a specialist in ocular models, Envol has positioned itself to be better equipped than ever to deliver comprehensive and reliable preclinical research solutions. Endpoint’s exceptional support and layered expertise have enabled us to tackle complex challenges, ensuring that our clients receive the highest quality results.
The Case Study: Achieving Success in Neuro Model CSF Collection
One of the most notable successes of our collaboration with Endpoint Preclinical came from a recent case study in the neuro space. A client came to us with a need to collect cerebrospinal fluid (CSF) repeatedly over an extended period—a procedure that was particularly challenging due to the technical precision required for catheter implantation. Not only did the procedure need to allow for large sample volumes, but it also required long-term consistency, which is critical for reliable data collection in neuro studies.
While Envol has long been known for our expertise in surgical procedures and neuro research, there are certain technical challenges in preclinical work that are simply difficult to navigate without granularly specific expertise. This is where the partnership with Endpoint proved invaluable.
Endpoint’s expert, Eric Adams, was brought in for his specialized knowledge in long-term repeated sampling of CSF fluid. Eric’s experience in this area helped us refine our techniques and improve the process significantly. For example, he suggested an alternative catheter tip placement, adjusting the placement from the thoracic region to a more optimal site, which made the sampling process more efficient and allowed us to collect larger volumes. This refinement addressed the client’s needs precisely, ensuring their study could proceed successfully.
The results of this collaboration have been exceptional—showing how our internal capabilities, combined with the appreciated expertise of Endpoint, can achieve great success for our clients. It was the right combination of talent, knowledge, and teamwork that allowed us to solve a complex issue efficiently and improve our client’s study outcomes.
A Collaboration Built on Strengths: Envol’s Leading Expertise and Endpoint’s Specialized Support
While the contribution from Endpoint’s team was extremely beneficial, our client came to us originally because of Envol Biomedical’s success and our own deeply-rooted strengths. Over the years, we have developed specialized capabilities in a wide range of therapeutic areas. Our team of scientists and surgeons are experienced in advanced techniques for neuro, ocular, cardiovascular, and interventional models, and we have continually demonstrated the ability to solve even the most complex challenges in preclinical research. The introduction of Endpoint’s involvement now serves to make these characteristics we’ve come to be known for even stronger.
Endpoint Preclinical brings specialized knowledge and insights that complement Envol’s expertise and enable us to tackle particularly niche issues that require a more focused skill set. Their involvement will be appreciated by our customers for its ability to elevate our work and help us achieve the best possible outcomes for them. The Endpoint team adds significant value by ensuring that our methods are refined and optimized, pushing our work to even higher standards of success.
Expanding the Partnership for the Future
This collaboration with Endpoint is just the beginning. As we continue to push the boundaries of our capabilities, we are excited to deepen our relationship with their team, especially in areas like ocular and cardiovascular models, where their specialized expertise adds tremendous value. By partnering with Endpoint, we ensure that our clients receive the most reliable and cutting-edge research services possible.
The ongoing relationship is already opening doors for new opportunities. Together, we are expanding our ability to conduct highly sophisticated studies, ensuring that Envol Biomedical remains at the forefront of preclinical research across multiple therapeutic areas.
Delivering Excellence for Our Clients
Our clients are at the heart of everything we do at Envol Biomedical. We understand the complexities involved in drug development and the critical role that preclinical research plays in the success of these programs. By continuing to work with the best and brightest experts, like those at Endpoint Preclinical, we can ensure that our clients receive the highest quality results, on time and on budget.
This partnership allows us to expand our capacity to meet the diverse needs of the industry while maintaining the personalized, flexible service that Envol is known for. We are proud of the success stories we have created together, and we look forward to continuing to work with Endpoint to provide unmatched value to our clients.
Look to Envol for Exceptional Preclinical Solutions
If you’re looking for a partner with expertise across neuro, ocular, cardiovascular, and interventional models, Envol Biomedical is here to support your research and drug development programs. With our comprehensive range of services and the added expertise from our collaboration with Endpoint Preclinical, we offer a unique advantage that can take your project to the next level.
We invite you to work with us—let’s achieve great success together with cutting-edge preclinical solutions backed by the combined strength of Envol Biomedical’s leading expertise and Endpoint Preclinical’s specialized support.
Reach out today and let’s get started on your next successful project.